<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>MCD.knit</title>

<script src="site_libs/header-attrs-2.18/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/jqueryui-1.11.4/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/font-awesome-5.1.0/css/all.css" rel="stylesheet" />
<link href="site_libs/font-awesome-5.1.0/css/v4-shims.css" rel="stylesheet" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>







<link rel="stylesheet" href="styles.css" type="text/css" />



<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}

.tocify-subheader {
  display: inline;
}
.tocify-subheader .tocify-item {
  font-size: 0.95em;
}

</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">Renal Medicine</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Research
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./trials.html">Trials</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    GEN
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./HTN.html">HTN</a>
    </li>
    <li>
      <a href="./CCF.html">CCF</a>
    </li>
    <li>
      <a href="./DKD.html">DKD</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    U&amp;E
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./acidbase.html">H+ &amp; HCO3</a>
    </li>
    <li>
      <a href="./na.html">Na</a>
    </li>
    <li>
      <a href="./k.html">K</a>
    </li>
    <li>
      <a href="./mg.html">MG</a>
    </li>
    <li>
      <a href="./renalbone.html">Ca2+ &amp; PO4</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    GN
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./MCD.html">MCD</a>
    </li>
    <li>
      <a href="./ANCA.html">ANCA</a>
    </li>
    <li>
      <a href="./IGAN.html">IGAN</a>
    </li>
    <li>
      <a href="./MPGN_C3G.html">MPGN &amp; C3G</a>
    </li>
    <li>
      <a href="./LUPUS.html">LUPUS</a>
    </li>
    <li>
      <a href="./FSGS.html">FSGS</a>
    </li>
    <li>
      <a href="./TMA.html">TMA</a>
    </li>
    <li>
      <a href="./GBM.html">GBM</a>
    </li>
    <li>
      <a href="./MN.html">MN</a>
    </li>
    <li>
      <a href="./Amyloid.html">Amyloid</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    CKD
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./project1.html">Checklist</a>
    </li>
    <li>
      <a href="./project1.html">Conservative care</a>
    </li>
    <li>
      <a href="./anaemia.html">Anaemia</a>
    </li>
    <li>
      <a href="./project1.html">Pruritis</a>
    </li>
    <li>
      <a href="./renalbone.html">CKD-MBD</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    TX
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./project1.html">Cheat sheet</a>
    </li>
    <li>
      <a href="./txnotes.html">Misc Notes</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    RRT
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./HD.html">HD</a>
    </li>
    <li>
      <a href="./project1.html">Home HD</a>
    </li>
    <li>
      <a href="./project1.html">HD Access</a>
    </li>
    <li>
      <a href="./project1.html">PD</a>
    </li>
    <li>
      <a href="./project1.html">CVVH</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    DRUGS
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./abx.html">Abx</a>
    </li>
    <li>
      <a href="./aboutme.html">HDU</a>
    </li>
    <li>
      <a href="./project1.html">Flozins</a>
    </li>
    <li>
      <a href="./rituxcyc.html">RITUX &amp; CYC</a>
    </li>
    <li>
      <a href="./Chemotherapy.html">Chemo</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    MISC
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./biopsy.html">Biopsy</a>
    </li>
    <li>
      <a href="./path.html">PATH</a>
    </li>
    <li>
      <a href="./preg.html">Pregnancy</a>
    </li>
    <li>
      <a href="./project1.html">PEX</a>
    </li>
    <li>
      <a href="./Lymphoproliferative.html">Lymphoproliferative</a>
    </li>
    <li>
      <a href="./covid19.html">SARS-Cov-2</a>
    </li>
    <li>
      <a href="./Tumour_Lysis.html">Tumour Lysis Syndrome</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    EDU
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./project1.html">Project part 1</a>
    </li>
    <li>
      <a href="./project2.html">Project part 2</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https:eoindosullivan.com">
    <span class="fas fa-home"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">




</div>


<div id="minimal-change-disease" class="section level1">
<h1>Minimal Change Disease</h1>
<ul>
<li>~10-15% of NS</li>
<li>30-50% can remit without treatment but may take up to 2 years</li>
<li>Probably can progress to FSGS</li>
<li>Over 80% of adults with MCD are steroid responsive.</li>
<li>50-70% of adult patients will relapse</li>
<li>1/3 patients may become frequent relapsers or steroid dependent <a
href="https://cjasn.asnjournals.org/content/2/3/445">Waldman et al,
cJASN 2007</a>.</li>
<li>Rapid onset of nephrotic sydrome</li>
<li>15% of adult cases are secondary: nonsteroidal anti-inflammatory
drugs, lithium, and lymphoproliferative disorders</li>
<li>Hypertension (25%–50%), hematuria (20%–30%), and AKI ( ATN?
)(20%–25%) are more common in adults</li>
<li>Rarely can lead to CKD, or even ESRD ( &lt;5%)</li>
<li>Anticoagulation: lower risk but perhaps if resistant?</li>
</ul>
<div id="typical-steroid-course" class="section level2">
<h2>Typical Steroid Course</h2>
<ul>
<li>Remission in ~50% adults by 8 weeks, 75-95% by 16.</li>
<li>1mg/kg, max 80mg po od - 4 weeks minimum, up to 16 weeks if waiting
on remission</li>
<li>Run 2-4 weeks post remission</li>
<li>Reduce to acheive total treatment of 4-6 months</li>
</ul>
</div>
<div id="relapse" class="section level2">
<h2>Relapse</h2>
<ul>
<li>Common, 65-80%</li>
<li>Usually first 3-6 months post remission</li>
<li>Age &lt;45 relapse more (?better immune system?)</li>
<li>1st relapse - repeat pred course</li>
<li>2 * courses in 6/months or 4/12 = frequent relapser</li>
<li>10-30% are frequent relapses and 15-30% are steroid dependant</li>
<li>Probably reasonable to give ritux although weight of evidence us for
cylophos. <a
href="https://jasn.asnjournals.org/content/25/4/850?ijkey=f2dc13c5abc54176d3ad3875aaf8460ec301ee27&amp;keytype2=tf_ipsecsha">Ruggenenti
et al JASN 2014</a></li>
<li>RTX (4 weekly doses of 375 mg/m2</li>
<li>Cyclophos po ~2mg/kg po od * 8-12 weeks. ( note dose adjusted by age
&amp; eGFR)</li>
<li>Partial remission is rare - rebiopsy for missed FSGS on bx?</li>
</ul>
</div>
</div>
<div id="anti-nephrin-antibodies" class="section level1">
<h1>Anti-Nephrin antibodies</h1>
<p><a
href="http://www.nephjc.com/freelyfiltered/42/anti-nephrin-antibodies-cause-mcd">Heres
a pretty good freely filtered</a> where the author <a
href="https://twitter.com/AstridWeins">Astrid Weins</a> is interviewed -
really enlightening ideas. Some conceptual highlights included</p>
<ul>
<li>Fine granular IgG dusting on <strong>almost all</strong> MCD bxs
!?</li>
<li>MCD-FSGS spectrum</li>
<li>~30% of MCD disease have circulating anti-nephrin antibodies
(NEPTUNE cohort)</li>
<li>Anti-nephrin is basically the perfect assault molecule vs slit
diaphragm.
<ul>
<li>IgG is freely filtered - just zooms past the slit diagram, is
continually replenished, hours of affinity perhaps, and it gets
instagibbed. Slit diaphragm integrity disrupted.</li>
<li>Doesnt need to accumulate and cause immune complexs( unlike
anti-PLAR2)</li>
<li>The antibody/antigen balance is probably very subtle and minor
effects will shift clinical picture ( steroids etc)</li>
<li>Fastest responders seem to loose ab over days.</li>
<li>No antibodies in patients in remission.</li>
</ul></li>
</ul>
<div id="the-pathology-of-acute-nephrotic-syndrome-in-mcd"
class="section level3">
<h3>The pathology of acute nephrotic syndrome in MCD</h3>
<ul>
<li>Effacement = nothing goes through = higher pressure</li>
<li>disrupted structure results in Bigger pore size</li>
<li>Nephrotic syndrome ramps up the pressure and overcomes the negative
charge of the endothelium which allows negative albumin.</li>
<li>Therefore dont need to alter endothelium, just need to overcome it
via ramping up pressure/pore size ( ?via nephrin -&gt; actin
cytoskeleton disruption)</li>
</ul>
</div>
<div id="recurrance-post-tx" class="section level3">
<h3>Recurrance post tx</h3>
<p>Rare. not sure how this fits with FSGS high recurrance.</p>
<p>Adult data here **</p>
<p>In rare cases <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212136/">Recurrance
post tx</a> of congenital nephrotic syndrome is thought to be driven by
anti-nephrin abs ( and responds accordingly to b-cell depletion) re
paediatrics, in congential (primary is typically AR vs
NPHS1(nephrin)/NPHS2) nephrotic syn and tx:</p>
<ul>
<li>Recurrance is rare in congential forms</li>
<li>Return of proteinuria is common in non congenital forms (80% of
total)</li>
</ul>
</div>
</div>
<div id="mintac" class="section level1">
<h1>Mintac</h1>
<p>The <a href="https://pubmed.ncbi.nlm.nih.gov/31953303/">mintac
trial</a></p>
<ul>
<li>Oral tacrolimus at 0.05 mg/kg twice daily vs or prednisolone at 1
mg/kg daily up to 60 mg daily.</li>
<li>The primary outcome was complete remission of nephrotic syndrome
after 8 weeks of therapy.</li>
<li>Secondary outcomes included remission of nephrotic syndrome at 16
and 26 weeks, rates of relapse of nephrotic syndrome, and changes from
baseline kidney function.</li>
</ul>
<p><strong>Mintac Protocol</strong></p>
<ul>
<li>Everyone got Acei, statin (if required)</li>
<li>Run tacro levels 6-8</li>
<li>At week 8, if inadequate clinical response, target blood trough
level was <strong>increased</strong> to 9-12 ng/ml.</li>
<li>12 weeks after achieving complete remission, tacrolimus doses were
titrated down over 8 weeks and stopped.<br />
</li>
<li>Participants in prednisolone arm received an initial dose of 1mg/kg
per day with a maximum dose of 60 mg/kg per day.</li>
<li>One week after achieving complete remission, the steroid dose was
halved for 4-6 weeks then gradually reduced and stopped over a further 6
weeks. Patients received a minimum of 16 weeks prednisolone. Bone and
gastric protection was with calcium carbonate/cholecalciferol
(1000mg/800IU) two tablets daily and omeprazole 20mg daily</li>
<li>Complete remission was defined as uPCR &lt;50 mg/mmol</li>
<li><strong>Results</strong> non inferior</li>
</ul>
<div class="figure">
<img src="images/mintac_visual_VAPablo.jpg" alt="" />
<p class="caption">abtract by Pablo Garcia</p>
</div>
</div>
<div id="key-papers" class="section level1">
<h1>Key Papers</h1>
<br>
<style>
div.blue { background-color:#e6f0ff; border-radius: 5px; padding: 20px;}
</style>
<div class = "blue">

<p><a href="https://www.nature.com/articles/nrneph.2016.147">Nature
reviews Nephrology: MCD-FSGS spectrum</a></p>
<ul>
<li>Early FSGS must have some early podocyte injury - some believe this
is the same intial injury and FSGS is end game</li>
<li>Genetic / environmental factors</li>
</ul>
<p><a
href="https://www.nature.com/https://cjasn.asnjournals.org/content/14/6/911/nrneph.2016.147">CJASN:
nice review on clinical features of MCD</a></p>
<p><br></p>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = false;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
